RankingsPricing
  1. US-listed companies
  2. AbbVie Inc.
  3. Financials
  4. Cash from investing

AbbVie Inc.ABBV

Market cap
$417.4B
P/E ratio
SummaryFinancials
Period EndCash from investing (Million USD)YoY (%)
Dec 31, 2024-20,820+936.34%
Dec 31, 2023-2,009+222.47%
Dec 31, 2022-623-73.42%
Dec 31, 2021-2,344-93.76%
Dec 31, 2020-37,557-6401.51%
Dec 31, 2019596-159.24%
Dec 31, 2018-1,006+267.15%
Dec 31, 2017-274-95.49%
Dec 31, 2016-6,074-53.05%
Dec 31, 2015-12,936+1296.98%
Dec 31, 2014-926-205.35%
Dec 31, 2013879

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)